These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7606743)

  • 1. Impairment of Moloney murine leukemia virus integration in a cell line underexpressing DNA topoisomerase II.
    Bouillé P; Subra F; Goulaouic H; Carteau S; Auclair C
    Cancer Res; 1995 Jul; 55(14):3211-7. PubMed ID: 7606743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y; Kerrigan D; Schwartz RE; Swack JA; McCurdy A
    Cancer Res; 1986 Jun; 46(6):3075-81. PubMed ID: 3009009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
    Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
    Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
    Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture.
    Tanizawa A; Pommier Y
    Cancer Res; 1992 Apr; 52(7):1848-54. PubMed ID: 1312902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration.
    Wei SQ; Mizuuchi K; Craigie R
    EMBO J; 1997 Dec; 16(24):7511-20. PubMed ID: 9405379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Moloney murine leukemia virus stem cell-specific repressor binding site.
    Kempler G; Freitag B; Berwin B; Nanassy O; Barklis E
    Virology; 1993 Apr; 193(2):690-9. PubMed ID: 8460481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
    Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense-mediated repression of DNA topoisomerase II expression leads to an impairment of HIV-1 replicative cycle.
    Bouillé P; Subra F; Mouscadet JF; Auclair C
    J Mol Biol; 1999 Jan; 285(3):945-54. PubMed ID: 9887261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S; Benchokroun Y; Larsen AK
    Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced integration of Moloney murine leukemia virus DNA with a mutant integration site occurs through recombination with VL30 DNA.
    Murphy JE; Goff SP
    Virology; 1994 Oct; 204(1):458-61. PubMed ID: 8091679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Moloney murine leukemia virus integration using polyamides targeting the long-terminal repeat sequences.
    Yang F; Belitsky JM; Villanueva RA; Dervan PB; Roth MJ
    Biochemistry; 2003 May; 42(20):6249-58. PubMed ID: 12755629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
    Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP
    Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
    Mo YY; Beck WT
    Oncol Res; 1997; 9(4):193-204. PubMed ID: 9268990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y; Schwartz RE; Zwelling LA; Kerrigan D; Mattern MR; Charcosset JY; Jacquemin-Sablon A; Kohn KW
    Cancer Res; 1986 Feb; 46(2):611-6. PubMed ID: 3000581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
    Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
    Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
    Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.